About Us

We specialize in the R&D and manufacturing of medical equipment and high-value consumables, offering innovative solutions.


Hengrui Medical is a technology-driven enterprise, specializing in advanced medical equipment, high-value consumables, and healthcare solutions. As a subsidiary of Jiangsu Hengrui Pharmaceutical Group Co., Ltd., we leverage pharmaceutical expertise to expand into the healthcare industry. Our core focus includes independent research, academic partnerships, and strategic investments to build a formidable product portfolio. Currently, we operate with five subsidiaries, including two R&D centers located in Suzhou and Shanghai. Hengrui Medical boasts a workforce of over 900 employees, including 200 dedicated to R&D, with over 54.2% holding master's degrees or above.


Our aim is market leadership and delivering comprehensive healthcare solutions. We excel in consumables like tumor, peripheral, and neural intervention, pioneering advanced drug delivery devices. We're continuously broadening our product range, such as life support, imaging support, and interventional support, reinforcing our market presence.

28 +


260 +


3000 +

Hospitals Coverage

500000 +

Procedures Coverage

Corporate Culture
Enterprise Mission

Our Mission

Providing Innovative and High-Quality Solutions for Physicians and Patients

Corporate Vision

Our Vision

Becoming a Globally Recognized Innovative Medical Device Company with Exceptional Capacities in Research and Development, Manufacturing, Sales and Service.

Corporate Values

Our Value

Customer-Centric, Value Sharing, Innovation, Dedication, Win-Win



Launched New Products, including EqualSpheres® and EvenSpheres® Narrow-size Embolic Microspheres, RAPIDTHRU® DA Micro Catheter and Guidewire, ImageMate® DSA Power Injector System, LIVSITE® Port, and More.


Officially Commenced Operations at the Headquarter, Achieving Sales Revenue of 1 Billion RMB.


Penetrated into the Life Support, Medical Materials, and Pharmaceutical Packaging Sector.


Commenced Construction for the Headquarters in Suzhou and Initiated R&D Projects in ECMO and CVAD.


Established the Subsidiary: Suzhou Hengrui Hongyuan Medical Co., Ltd.


Developed and Formulated of the Hengrui Medical 2017-2025 8-Year Plan.


Founded the Corporate Entity Suzhou Hengrui Medical Co., Ltd. and Formulated the Corporate Strategy.


Acquired Callisyn Biomedical and Established Suzhou Hengrui Disheng Medical Co., Ltd.


Established Shanghai Hongchuang R&D Center.